Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility
about
Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repairMechanisms and regulation of mitotic recombination in Saccharomyces cerevisiaePALB2: the hub of a network of tumor suppressors involved in DNA damage responsesRAD51C germline mutations in breast and ovarian cancer cases from high-risk familiesGenetic testing for RAD51C mutations: in the clinic and communityContribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the PopulationIdentification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancerFull-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.Single nucleotide polymorphisms in noncoding regions of Rad51C do not change the risk of unselected breast cancer but they modulate the level of oxidative stress and the DNA damage characteristics: a case-control study.Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients.Genotyping of fanconi anemia patients by whole exome sequencing: advantages and challenges.Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families.Mutation screening of RAD51C in high-risk breast and ovarian cancer families.HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis.FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.Hereditary breast cancer syndromes and genetic testing.Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.Estrogen induces RAD51C expression and localization to sites of DNA damageGermline mutations in RAD51C in Jewish high cancer risk families.An increased risk of ovarian cancer associated with polymorphism in BRCC5 gene in Caucasian populations.Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers.Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing.Germline breast cancer susceptibility gene mutations and breast cancer outcomes.RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer familiesGenetics of breast cancer in African populations: a literature review
P2860
Q24338777-E3AEDD93-57F5-47AE-89EC-A9B90B31F311Q26864428-AED0B83F-F49F-41B0-9A12-F9F88A37C3AAQ28243398-21E38980-0D88-4F33-BFF2-EB364A0FE405Q28249994-62127C39-1569-4DB5-ACCF-4CF51751B4E7Q28253197-D1B1339D-51D3-4C24-8221-14BA5047D0B7Q28266112-65C6622E-82C0-48C4-B7A1-2A15742844F8Q28271817-CC9310F9-26E5-4D99-88E9-DBEB01B51F83Q34288968-65C382D7-0957-41A5-80F7-9F28DA9AEEAEQ34400764-FC8CAAE5-C5C2-4F8B-9F8B-1932CA33832EQ34486808-FBC229F1-BC52-43B9-866C-DDFEFBFA3B55Q34534327-63E0445F-B111-4114-B827-402FBB9916E5Q35889909-A86F79B9-AE0D-49B9-8057-F95E4163DF0AQ36162179-1A4B7203-B4CC-4FB0-BCD8-78F055AF9394Q37331571-1006EC74-959F-4AB0-B2D2-048F314C5850Q37394076-B1CB5597-07FF-483C-861E-C4DF38DF4045Q38266306-A54F5E40-E647-4E33-9E21-D672F192465CQ38614203-278F0094-6BDF-4215-A5DA-037368AED6DEQ40035188-4687589E-4347-42DD-B524-D8547C43AADFQ42345398-2C95DD44-3965-4CDD-B484-0FD9FC422FAFQ44358800-2D054DE6-362C-4925-9F87-6FA04EE2521CQ45188292-14DFBD1E-0239-461F-B361-D9C1DE08792CQ48097657-22EADCE1-DD9F-467A-9F47-B6F079B5F198Q49032312-A3B30AE1-CEA7-4A01-91B3-51A6AE2FED34Q54945937-B961F07E-0041-4117-AF1C-822452E49006Q57083786-C40330DF-0F5E-45C9-8FA3-C16C0DC9F33BQ57112866-EEB4224D-683B-46EC-B0DB-D55D4B674B96
P2860
Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility
description
article
@en
im Juli 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2011
@uk
name
Further evidence for the contr ...... ovarian cancer susceptibility
@en
Further evidence for the contr ...... ovarian cancer susceptibility
@nl
type
label
Further evidence for the contr ...... ovarian cancer susceptibility
@en
Further evidence for the contr ...... ovarian cancer susceptibility
@nl
prefLabel
Further evidence for the contr ...... ovarian cancer susceptibility
@en
Further evidence for the contr ...... ovarian cancer susceptibility
@nl
P2093
P2860
P50
P1476
Further evidence for the contr ...... ovarian cancer susceptibility
@en
P2093
Anna von Wachenfeldt Wäppling
Annika Rosengren
Karin Sundfeldt
Maarit Anttila
Maria Haanpää
Mikko Vuorela
Ulla Puistola
P2860
P2888
P304
P356
10.1007/S10549-011-1677-X
P407
P577
2011-07-13T00:00:00Z